Which has preferable earnings & valuation, APLMW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A Alvotech $559.42M N/A N/A N/A N/A

Is APLMW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A Alvotech N/A N/A N/A

Does the media favor APLMW or ALVOW?

In the previous week, Apollomics had 1 more articles in the media than Alvotech. MarketBeat recorded 3 mentions for Apollomics and 2 mentions for Alvotech. Alvotech's average media sentiment score of 0.93 beat Apollomics' score of 0.29 indicating that Alvotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apollomics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Alvotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, ARAV or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A Apollomics $8.50M N/A N/A N/A N/A

Is ARAV or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A Apollomics N/A N/A N/A

Which has stronger earnings & valuation, APLMW or BIAFW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A bioAffinity Technologies $5.85M N/A N/A N/A N/A

Is APLMW or BIAFW more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A bioAffinity Technologies N/A N/A N/A

Does the media refer more to APLMW or BIAFW?

In the previous week, Apollomics and Apollomics both had 3 articles in the media. bioAffinity Technologies' average media sentiment score of 0.73 beat Apollomics' score of 0.29 indicating that bioAffinity Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apollomics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral bioAffinity Technologies 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, APLMW or BIVIW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Apollomics $8.50M N/A N/A N/A N/A BioVie N/A N/A N/A N/A N/A

Is APLMW or BIVIW more profitable?

Company Net Margins Return on Equity Return on Assets Apollomics N/A N/A N/A BioVie N/A N/A N/A

Does the media prefer APLMW or BIVIW?

In the previous week, Apollomics had 1 more articles in the media than BioVie. MarketBeat recorded 3 mentions for Apollomics and 2 mentions for BioVie. BioVie's average media sentiment score of 1.23 beat Apollomics' score of 0.29 indicating that BioVie is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Apollomics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BioVie 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation & earnings, CDIOW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cardio Diagnostics $14.45K N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is CDIOW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets Cardio Diagnostics N/A N/A N/A Apollomics N/A N/A N/A

Apollomics (APLMW) Competitors

$0.02 0.00 (-0.55%)

As of 03:48 PM Eastern

Compare

APLMW vs. ALVOW, ARAV, BIAFW, BIVIW, and CDIOW

Should you buy Apollomics stock or one of its competitors? Apollomics's main competitors and comparable companies include Alvotech (ALVOW), Aravive (ARAV), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Apollomics compare to Alvotech?

Apollomics (NASDAQ:APLMW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, media sentiment, valuation, dividends and analyst recommendations.

In the previous week, Apollomics had 1 more articles in the media than Alvotech. MarketBeat recorded 3 mentions for Apollomics and 2 mentions for Alvotech. Alvotech's average media sentiment score of 0.93 beat Apollomics' score of 0.29 indicating that Alvotech is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apollomics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Alvotech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
Alvotech	$559.42M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Summary

Alvotech beats Apollomics on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to Aravive?

Aravive (NASDAQ:ARAV) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, media sentiment, valuation, profitability, analyst recommendations, institutional ownership, risk and dividends.

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

In the previous week, Apollomics had 3 more articles in the media than Aravive. MarketBeat recorded 3 mentions for Apollomics and 0 mentions for Aravive. Apollomics' average media sentiment score of 0.29 beat Aravive's score of 0.00 indicating that Apollomics is being referred to more favorably in the news media.

Company	Overall Sentiment
Aravive	Neutral
Apollomics	Neutral

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

Summary

Apollomics beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Apollomics compare to bioAffinity Technologies?

Apollomics (NASDAQ:APLMW) and bioAffinity Technologies (NASDAQ:BIAFW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

In the previous week, Apollomics and Apollomics both had 3 articles in the media. bioAffinity Technologies' average media sentiment score of 0.73 beat Apollomics' score of 0.29 indicating that bioAffinity Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apollomics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
bioAffinity Technologies	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
bioAffinity Technologies	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A

Summary

Apollomics and bioAffinity Technologies tied by winning 1 of the 2 factors compared between the two stocks.

How does Apollomics compare to BioVie?

Apollomics (NASDAQ:APLMW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Apollomics	$8.50M	N/A	N/A	N/A	N/A
BioVie	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Apollomics	N/A	N/A	N/A
BioVie	N/A	N/A	N/A

In the previous week, Apollomics had 1 more articles in the media than BioVie. MarketBeat recorded 3 mentions for Apollomics and 2 mentions for BioVie. BioVie's average media sentiment score of 1.23 beat Apollomics' score of 0.29 indicating that BioVie is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Apollomics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BioVie	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Apollomics beats BioVie on 2 of the 3 factors compared between the two stocks.

How does Apollomics compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardio Diagnostics	$14.45K	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Cardio Diagnostics	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

In the previous week, Apollomics had 2 more articles in the media than Cardio Diagnostics. MarketBeat recorded 3 mentions for Apollomics and 1 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 1.89 beat Apollomics' score of 0.29 indicating that Cardio Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
Cardio Diagnostics	Very Positive
Apollomics	Neutral

Summary

Apollomics beats Cardio Diagnostics on 2 of the 3 factors compared between the two stocks.

Get Apollomics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding APLMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

APLMW vs. The Competition

Export

Metric	Apollomics	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$3.71B	$6.98B	$13.04B
Dividend Yield	N/A	3.76%	2.58%	10.72%
P/E Ratio	N/A	10.68	269.86	25.30
Price / Sales	N/A	1,308.25	601.81	101.06
Price / Cash	N/A	103.01	70.53	50.75
Price / Book	N/A	17.49	13.08	6.33
Net Income	N/A	-$13.32M	$3.45B	$347.70M
7 Day Performance	N/A	1.74%	1.12%	1.07%
1 Month Performance	N/A	1.60%	1.79%	1.03%
1 Year Performance	N/A	56.43%	67.69%	20.77%

Apollomics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
APLMW Apollomics	N/A	$0.02 -0.6%	N/A	-30.7%	$0.00	$8.50M	N/A	59	Short Interest Increase Gap Down
ALVOW Alvotech	N/A	$0.15 flat	N/A	-87.2%	$0.00	$559.42M	N/A	4	Upcoming Earnings
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.09 -0.3%	N/A	-26.6%	$0.00	$5.61M	N/A	10	News Coverage Upcoming Earnings
BIVIW BioVie	N/A	$0.38 -2.6%	N/A	N/A	$0.00	N/A	N/A	N/A	News Coverage High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:APLMW) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Apollomics (APLMW) Competitors